HOOK (hookipapharma.com) Sof foyda

HOOK (hookipapharma.com) - kompaniyaning tovar belgisi

HOOKIPA Pharma Inc. (HOOK) rahbariyati hamkorliklar orqali xarajatlarni samarali nazorat qilmoqda va GURU.Markets terminalidan olingan ushbu grafik kompaniyaning ortiqcha daromadlarini aks ettiradi, bunda joriy ko'rsatkich 0.00 ni tashkil etgan. Brendning ilmiy nufuzi innovatsion immunoterapiya platformasi va sanoat gigantlarining ishonchi bilan mustahkamlanmoqda. Strategiya energiyani tejovchi texnologiyalar va laboratoriya emissiyalarini tozalash tizimlarini joriy etish orqali ESG standartlariga rioya qilish bilan yakunlanadi.

HOOK (HOOKIPA Pharma Inc.) Sof foyda tarixi 04.07.2022dan 24.08.2025gacha

hookipapharma.com (HOOK) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari HOOKIPA Pharma|HOOK - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi HOOKIPA Pharma Inc.|HOOK - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati HOOKIPA Pharma|HOOK - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi hookipapharma.com|HOOK - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati HOOKIPA Pharma Inc.|HOOK - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati HOOKIPA Pharma|HOOK - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar HOOKIPA Pharma Inc.|HOOK - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi HOOKIPA Pharma|Shoshilinch likvidlik hookipapharma.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
HOOK - Sof foyda
Kompaniyaning jamlanma tahlili:HOOKIPA Pharma Inc.
HOOKIPA Pharma, Inc. asosiy tovari

Ushbu ko'rsatkich sof foydaning Fed stavkalari dinamikasi va kreditlash xarajatlariga bo'lgan operatsion sezgirligini o'lchaydi, bu esa moliyaviy barqarorlikni real vaqt rejimida kuzatish imkonini beradi. Grafikda ko'rsatilgan foyda marjalarining pasayishi naqd pul defitsitining ortayotganidan dalolat beradi, bu esa yuqori R&D xarajatlari bosimi va daromad yo'qligi sababli tashqi moliyalashtirishga bog'liqlik tufayli HOOKIPA Pharma Inc. (HOOK) uchun kritik ahamiyatga ega.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|Yakuniy foyda PHAR (Pharming Corp)|Nektar Therapeutics (NKTR) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi upstreambio.com (UPB)|Kompaniyaning sof foydasi Zenas Biopharma|Kompaniyaning sof daromadi Immunome Inc IMNM|Kompaniyaning sof foydasi Gossamer Corp (GOSS)|Sof foyda KalVista Corp (KALV)|Sof foyda SEPN (Septerna Inc)|Sof moliyaviy natija pieris.com (PVLA)|SVRA - Kompaniyaning sof foydasi|Soliqdan keyingi foyda RIGL|ANAB: Sof foyda|Astria Corp (ATXS) - Sof foyda|Sof daromad ENGN|RAPT: Yakuniy foyda|Kompaniyaning sof foydasi Aerovate Therapeutics Inc (JBIO)|ACRS: Soliqdan keyingi foyda|Sof foyda KYTX (Kyverna)|Yakuniy foyda TLSA|Cabaletta Bio, Inc. - Sof foyda|VTYX - Sof foyda|Theratechnologies (THTX) - Kompaniyaning sof foydasi|Avalo Therapeutics, Inc. - Yakuniy foyda|Kompaniyaning sof foydasi Eledon|Sof daromad Agenus, Inc (AGEN)|Sof foyda CLYM|Sof foyda zurabio.com (ZURA)|aTyr Pharma - Sof daromad|Yakuniy foyda ADAG|Ikena Oncology, Inc. - Sof foyda|Sof moliyaviy natija Shattuck Labs, Inc. STTK|equilliumbio.com (EQ) - Kompaniyaning sof foydasi|Kompaniya foydasi CNTB|IMUX (Immunic Therapeutics) - Sof foyda|Sof daromad Atara Biotherapeutics Inc (ATRA)|Sof daromad IFRX (InflaRx N.V.)|Sof moliyaviy natija X4 Pharmaceuticals, Inc|Sof foyda ACET (Adicet Bio, Inc.)|Yakuniy foyda CELU|INMB - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Barinthus Biotherapeutics PLC|Kezar Life Sciences, Inc (KZR) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi SAB Biotherapeutics Inc (SABS)|Kompaniyaning sof foydasi Akari Therapeutics|Sof foyda Enlivex Therapeutics, Ltd.|Kompaniyaning sof foydasi Q32 Bio Inc. (QTTB)|GOVX: Soliqdan keyingi foyda|Sof foyda EDSA (Edesa)|Yakuniy foyda IBIO|Carisma Tx - Sof foyda|XTLB - Sof foyda|boltbio.com (BOLT) - Kompaniyaning sof foydasi|HCW Biologics - Yakuniy foyda|Kompaniyaning sof foydasi Aptevo Therapeutics, Inc.|Sof daromad aimimmuno.com (AIM)|Sof foyda ADTX|Sof foyda gribio.com (GRI)|XORTX Therapeutics - Sof daromad|Yakuniy foyda HIND|Revelation Bio - Sof foyda|Sof moliyaviy natija Indaptus Corp INDP|Scinai Immunotherapeutics (SCNI) - Kompaniyaning sof foydasi|Sof daromad CalciMedica|Kompaniyaning sof foydasi Affimed NV|Sof daromad Allakos Therapeutics (ALLK)|Sof daromad IGMS (IGM Biosciences, Inc.)|Sof foyda iTeos Pharma (ITOS)|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP: Kompaniya foydasi|Third Harmonic Bio, Inc. - Sof foyda